Get informed when a big investor buys or sells
+ Follow52.08%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Cutera (CUTR) currently reports a ROE of 52.08%. That is above the Healthcare sector average of 13.26%. Use the charts on this page to explore Cutera's ROE history and peer comparisons.
Cutera's ROE of 52.08% is higher than the Healthcare sector average of 13.26%. That is roughly 292.7% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Cutera's current 52.08% should be judged against Healthcare norms (sector average: 13.26%) and against CUTR's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of 52.08%, then check the historical chart for trend and the peer comparison chart for relative positioning. The Healthcare average is 13.26%. From there, open related valuation or income-statement pages for Cutera, and consider following CUTR for alerts when major investors trade the stock.
Cutera is classified in the Healthcare sector. On ROE, it currently shows 52.08% versus a sector average near 13.26%. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing CUTR with unrelated industries.